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Open acceAbstract. Trichiasis is the sight-threatening consequence of conjunctival scarring in trachoma, the most
common infectious cause of blindness worldwide. Trachomatous trichiasis is the result of multiple
infections from childhood with Chlamydia trachomatis, which causes recurrent chronic inflammation in
the tarsal conjunctiva. This produces conjunctival scarring, entropion, trichiasis, and ultimately blinding
corneal opacification. The disease causes painful, usually irreversible sight loss. Over eight million people
have trachomatous trichiasis, mostly those living in poor rural communities in 57 endemic countries. The
global cost is estimated at US$ 5.3 billion. The WHO recommends surgery as part of the SAFE strategy for
controlling the disease.We examine the principles of clinical management, treatment options, and the
challenging issues of providing the quantity and quality of surgery that is needed in resource-poor
settings. (Surv Ophthalmol 57:105--135, 2012. 2012 Elsevier Inc. )Open access under CC BY license.Key words. Entropion  eyelash  eyelid  surgery  trachoma  trichiasisI. Introduction
Trachoma is the leading infectious cause of blind-
ness worldwide108—a major ophthalmic public
health problem in some of the world’s poorest
regions. Recurrent Chlamydia trachomatis infection in
childhood results in entropion and trichiasis many
years later. This may cause painful and (usually)
irreversible blindness.
The World Health Organization (WHO) is leading
a global campaign to eliminate blinding trachoma by
the year 2020 (GET2020) through the implementa-
tion of the SAFE Strategy: Surgery for trichiasis,
Antibioticdistribution to control chlamydial infection,
Facial cleanliness, and Environmental improvements
to reduce its transmission.145 Trichiasis is the major
risk factor for corneal opacification,30 and thus105
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ss under CC BY license.treating trichiasis is central to preventing visual loss.
There are many challenges, however, in the effective
management of trichiasis. The backlog of untreated
cases remains high, reported surgical outcomes are
often disappointing, endemic communities are fre-
quently inaccessible, and questions remain over the
optimal procedure, surgical training, surgical quality,
and productivity.We examine the principles of clinical
management, treatment options, and the challenging
issues of providing the quantity and quality of surgery
that is needed in resource poor settings.II. Global Distribution and Burden
In 2009 WHO estimated that approximately 41
million people have active trachoma.88 This represents0039-6257
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reflecting the success of the ‘‘AFE’’ components of
control programs, more accurate disease estimates,
and economic development in some trachoma en-
demic areas.146 Over the same period, however, there
has been a modest increase in the backlog of
unoperated trachomatous trichiasis (TT) from 7.6
million to 8.2 million cases, despite expanding tri-
chiasis surgery services in many endemic countries. It
may takemany years before the control ofC. trachomatis
infection in endemic communities translates into
a reduction in the incidence of new trichiasis cases.
Trachoma is currently endemic in 57 countries,
most of which are in sub-Saharan Africa and Asia.88
The highest disease prevalence estimates come from
countries in the Sahel belt and East Africa. Areas of
Ethiopia and Sudan report active disease in 60% of
children and trichiasis in 10% of adults.53,83 The
economic impact of blinding trachoma on individ-
uals and communities is high, particularly as
affected communities are already poor. The most
recent published estimate of the economic cost of
visual loss from trachoma, which is thought to affect
over 2 million people, is US$ 5.3 billion per year and
significantly more if other debilitating symptoms of
the disease, such as photophobia and pain, are
taken into account.56III. Pathophysiology and Natural History
of Trachomatous Trichiasis
The disease process begins in early childhood with
recurrent Chlamydia trachomatis (Serovars A, B, B1,
and C) infection of the conjunctival epithelium,
which provokes a follicular conjunctivitis, known as
active trachoma (Fig. 1A). This is characterized by an
inflammatory cell infiltrate and a pro-inflammatory
cytokine response.27,50,95 In endemic communities
children are repeatedly infected, and this causes
chronic inflammation.137 This leads to conjunctival
scarring (Fig. 1B), cicatricial entropion, and trichiasis
(Fig. 1C). Although episodes of C. trachomatis in-
fection become shorter and less severe as individuals
get older, inflammation still occurs, and scarring
worsens over many decades.7,26,31 Eventually, the
abrading lashes or secondary microbial keratitis cause
corneal opacification (Fig. 1C). Severe microbial
keratitis can ultimately result in phthisis (Fig. 1D).
The visual loss is both painful and irreversible, as
keratoplasty is rarely available and is at high risk for
failure in trachoma-endemic countries.151IV. Clinical Assessment
The vast majority of individuals with TT live in
trachoma-endemic countries.However,withmigration,TT cases occasionally present to ophthalmologists
elsewhere. Patients are usually symptomatic. They may
report eyelashes touching their eye or have less-specific
symptoms suchas foreignbody sensation, tearing, pain,
or photophobia. Many patients self epilate and should
be asked about this to help gauge the severity of the
trichiasis, although in some settings they may be
reticent about admitting to this. Other improvised or
traditional treatments, such as cutting eyelashes or
using hot ash to burn away lashes, may have been tried.
It is important to ask about previous lid surgery,
including operations performed by traditional healers,
as repeat surgery is usually more difficult. A family
history can be informative: C. trachomatis infection and
the disease it causes tend to cluster, with some families
more severely affected than others. An individual’s risk
ofdeveloping scarring is a complex interactionbetween
the lifetime exposure toC. trachomatis infection and the
human immuno-fibrogenic responses.
In assessing patients with TT for treatment,
several features need to be evaluated: lid and lash
position, the tarsal conjunctiva, and the cornea.
WHO has developed several systems for the clinical
grading of trachoma. Two of these are currently in
use: the detailed ‘‘FPC system’’, which is primarily
a research tool (Table 1) and the Simplified WHO
Trachoma Grading System (Table 2), which is in
routine use in control programs.44,120 The exami-
nation can be performed with a pair of loupes and
a handlight. Visual acuity should be measured.A. LID AND LASH POSITION
Lashes may come into contact with the globe for
several reasons that may coexist in the same eyelid:
(1) entropion, (2) misdirected lashes (abnormal
direction, but originating from follicles that are in
the lash line; Fig. 1E), and (3) metaplastic lashes
(originating from follicles that are in an abnormal
location; Fig. 1F).10,103a The number and location of
lashes touching the globe should be noted to gauge
the severity. A few temporal lashes touching the
conjunctiva are less problematic than central lashes
in constant contact with the cornea. TT may occur
with or without frank entropion. There is no
standardized entropion grading system; it is useful
to note the extent and degree of any entropion by
looking for inward rotation of the lid margin in the
primary position, however. In established entropion
there is often ‘‘rounding’’ of the normally sharp
edge where the tarsal conjunctival joins the lid
margin. Lagophthalmos can occur in severe disease
or as a result of previous lid surgery.77 Although TT
occurs primarily in the upper lid, we have observed
some people have lower lid TT.102a For research
purposes trichiasis has sometimes been subdivided,
Fig. 1. The clinical signs of trachoma. A: Active trachoma with both follicles and intense inflammation. B: Trachomatous
conjunctival scarring. C: Entropion trichiasis and corneal opacity. D: Phthisis. E: Misdirected lashes. F: Metaplastic lashes.
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eyelashes touching the globe) and major TT (six or
more eyelashes touching the globe).105
B. TARSAL CONJUNCTIVA
The upper eyelid should be everted and exam-
ined for signs of trachoma. Adults rarely have active
follicular conjunctivitis; however, eyes with TT
frequently have inflammation of the tarsal conjunc-
tiva. This could be caused by infection (chlamydial
and non-chlamydial), mechanical irritation, or an
immune-mediated response.30 Conjunctival scarring
ranges from a few fine white lines to extensive dense
scar tissue. Sometimes an Arlt’s line is seen—a thick,
dense, horizontal band of scarring. Entropion
brings squamous epithelium from anterior to the
gray line into a new environment, where factors,
perhaps in the tears, cause it to take on a conjunc-
tival phenotype. This gives the appearance of an
anterior movement of the muco-cutaneous junction,
normally posterior to the meibomian gland orifices,
described as ‘‘conjunctivalization of the lid mar-
gin.’’77 In individuals with more severe conjunctivalscarring there may be squamous metaplasia second-
ary to chronic inflammation and dryness of the
ocular surface.C. CORNEA
The cornea may develop opacification from direct
trauma by the TT or from secondary bacterial in-
fection. Fibrovascular pannus usually affects the upper
third of the cornea, although this tends to be more
prominent in childrenwith active trachoma.Herbert’s
pits are small depressions, often pigmented, at the
superior limbus and are the residua of limbal follicles.
In severe cases the globemay become phthisical. Non-
trachomatous causes of corneal opacity, such as
microbial keratitis, trauma, vitamin A deficiency, and
congenital measles, are also relatively common in
trachoma endemic communities.D. DIFFERENTIAL DIAGNOSIS
Cicatrizing conjunctivitis can develop in a wide
variety of conditions. In some of these, the scarring
maybe severe enough todistort the eyelids, leading to
TABLE 1
The WHO Trachoma Grading System (FPC)
Grade Description
Upper Tarsal Follicles (F)
F 0 No follicles.
F 1 Follicles present, but no more than 5 in zones 2 and 3 together.
F 2 More than 5 follicles in zones 2 and 3 together, but less than 5 in zone 3.
F 3 Five or more follicles in each of the three zones.
Upper tarsal papillary hypertrophy and diffuse inflammation (P)
P 0 Absent: normal appearance
P 1 Minimal: individual vascular tufts (papillae) prominent, but deep subconjunctival vessels
on the tarsus not obscured.
P 2 Moderate: more prominent papillae, and normal vessels appear hazy, even when seen
by the naked eye.
P 3 Pronounced: conjunctiva thickened and opaque, normal vessels on the tarsus are hidden
over more than half of the surface.
Conjunctival scaring (C)
C 0 No scarring on the conjunctiva.
C 1 Mild: fine scattered scars on the upper tarsal conjunctiva, or scars on other parts of
the conjunctiva.
C 2 Moderate: more severe scarring but without shortening or distortion of the upper tarsus.
C 3 Severe: scarring with distortion of the upper tarsus.
Trichiasis and/or entropion (T/E)
T/E 0 No trichiasis and/or entropion.
T/E 1 Lashes deviated towards the eye, but not touching the globe.
T/E 2 Lashes touching the globe but not rubbing the cornea.
T/E 3 Lashes constantly rubbing the cornea.
Corneal scarring (CC)
CC 0 Absent.
CC 1 Minimal scarring or opacity but not involving the visual axis, and with clear central cornea.
CC 2 Moderate scarring or opacity involving the visual axis, with the papillary margin visible
through the opacity.
CC 3 Severe central scarring or opacity with the papillary margin not visible through the opacity.
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endemic trachoma (C. trachomatis), adenovirus, and
Corynebacterium diphtheria. Several autoimmune con-
ditions cause conjunctival scarring: mucus mem-
brane pemphigoid, Stevens-Johnson syndrome,
graft-versus-host disease, atopic keratoconjunctivitis,
and linear IgA disease. Conjunctival scarring can also
develop in ocular rosacea, sarcoidosis, following
chemical injuries, and with specific drugs (practolol,
topical adrenaline). Metaplasia and misdirection of
the eyelashes in the absence of entropion candevelop
in inflammatory conditions that affect the lid margin
(e.g., blepharitis and ocular rosacea).TABLE
The WHO Simplified System for
Grade
Trachomatous inflammation -- follicular TF The p
tars
Trachomatous inflammation -- intense TI Prono
that
Trachomatous scarring TS The p
Trachomatous trichiasis TT At lea
Corneal opacity CO EasilyV. Anatomy of the Upper Eyelid
The upper eyelid is formed of the anterior and
posterior lamellae, separated superiorly by the orbital
septum (Fig. 2). The anterior lamella consists of skin,
subcutaneous tissue, the orbicularis oculi muscle
fibers, and the insertion slips of the levator aponeu-
rosis. The posterior lamella is formed of the tarsal
plate containing the meibomian glands, sub-
epithelial conjunctival stroma, Mu¨ller’s muscle (con-
tinuous with levator palpebrae superioris), and the
conjunctival epithelium. The upper eyelid receives its
blood supply through an anastomosis of the medial2
the Assessment of Trachoma
Description
resence of five or more follicles (O0.5 mm) in the upper
al conjunctiva
unced inflammatory thickening of the tarsal conjunctiva
obscures more than half of the deep normal vessels
resence of scarring in the tarsal conjunctiva
st one lash rubs on the eyeball
visible corneal opacity over the pupil
Fig. 2. Cross-section of the upper eyelid.
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ophthalmic artery. The palpebral arteries form the
marginal and peripheral arterial arches, which run
the length of the lid. Venous blood drains medially
into the ophthalmic and angular veins and laterally
into the superficial temporal vein. The lymphatic
drainage from the lateral two-thirds of the upper lid
is to the superficial parotid nodes, and the medial
third drains to the submandibular node. The upper
lid receives its sensory innervation from the ophthal-
mic division of the trigeminal nerve via the infratro-
chlear, supratrochlear, supraorbital, and lacrimal
nerves. Orbicularis oculi is innervated by temporal
and zygomatic branches of the facial nerve, and the
smooth muscle is supplied by sympathetic nervefibres from the superior cervical ganglion. Superiorly
the orbital septum demarcates the upper end of the
anterior lamella from the pre-aponeurotic fat pad.VI. A Historical Perspective on Trichiasis
Treatment
Trachoma was endemic in the ancient world. The
earliest known written references are found in The
Ebers Papyrus from Egypt (ca. 1600 BCE) which
advises treatment with myrrh, lizard, or bat’s blood
or simply pulling out the lashes for trichiasis; and in
the writings of Susruta in India (ca. 1000--500 BCE),
which recommends cautery, lid incision, and
110 Surv Ophthalmol 57 (2) March--April 2012 RAJAK ET ALeverting sutures for entropion and trichiasis.25,34,69
Forceps thought to have been used to remove
eyelashes have been found in many Egyptian tombs.
The Hippocratic corpus (5th--4th century BCE)
contains the first known use of the word trichosis
(abnormal hair growth of the eye) and gives what is
probably the earliest surviving description of a sur-
gical treatment where it instructs that trichosis of the
eye should be treated by:. pass [ing] a thread through the eye of
a needle; then piercing through along the angle
of the upper extension of the eye-lid in a down-
ward direction, draw the needle through; do the
same again below this. Now pulling the threads
tight, stitch them together, and keep them
bound fast until the fall off. If this suffices, fine;
if it fails, do the same again.41,68Surgery for trichiasis was said to be one of the more
common procedures in the Roman Empire.74 The
operation involved eyelash epilation and lash follicle
cautery with a hot iron, which has parallels to modern
lash-root cautery procedures. Although the disease
had evidently been present and described for millen-
nia, the first surviving use of the word trachoma, from
trachys [rough], is in theMateria Medica of Dioscorides
Pedanius, written in the 1st century CE.46 Soon after
Galen (129--200 CE), classified trachoma into five
stages that are similar to those that we use today and
included sycosis (scarred) and tylosis (trichiasis).58 In
the 7th century CE, Paul of Aegina wrote a major
medical compendium drawing on the medical knowl-
edge of Hellenistic Alexandria and the Roman
physicians. He described the treatment of trichiasis
by removing a piece of eyelid skin by clamping a foldof
skin between two pieces of reed. This technique
produces a degree of lid eversion and was still used
by traditional healers in Myanmar in the 1970s.140
Trichiasis treatment remained essentially unchanged
from ancient times until the 19th century, when new
oculoplastic procedures started to be developed for
entropion.3,117VII. Treatments for Trichiasis and
Entropion
During the course of the last centurymany different
procedures for the treatment of TT have been
described. Trachoma-control programs in endemic
countries routinely use someof these; others are rarely
performed except by oculoplastic specialists. The
variety of options suggests that, on the one hand,
the ‘‘perfect’’ solution does not exist and that the
treatment should ideally be tailored to the individual.
On the other hand, the high prevalence of TTand thelimited surgical services in most endemic countries
demands a simple, quick procedure that can be taught
to and carried out by non-ophthalmologists with the
most basic equipment in the most basic settings.
Treatment options broadly divide into those that only
treat the lashes and those that also correct the
underlying anatomical eyelid abnormality.
A. LASH TREATMENTS
1. Epilation
Individuals with trichiasis often pull out their own
eyelashes, usually with locally made forceps, but
sometimes with fingers.23,135 Indeed, it is not un-
common to meet patients who have removed all of
their lashes. In some settings patients whodonothave
access to forceps use hot coals to burn away lashes or
scissors to cut them. There is limited data on the
effectiveness of epilation in preventing blindness. In
one large cross-sectional analysis, epilation was
common and associated with a significantly lower
risk of corneal opacification in eyes with ‘‘moderate’’
or ‘‘severe’’ entropion, but no difference was found
for eyes with only ‘‘mild’’ entropion.135 However,
corneal opacification occurred in less than 10% of
patients in this study with ‘‘mild’’ entropion.
It has been suggested that poorly conducted
epilation leaves broken, short, sharp lash stubs that
do more damage than the original long lashes,44,107
but there is no published data to support this view.
Patients with trichiasis tend to avoid gaze positions
that lead to contact between sharp lashes and the
cornea. Additionally, if the lash is not broken during
epilation, the re-growing lash does not appear to be
sharper or more abrasive than the one it replaces.
There is a consensus that surgery is indicated for
moderate to severe trichiasis, especially if it threatens
the cornea. In contrast, opinion and practice are
divided on the role of epilation in themanagement of
mild TT. There have been no trials comparing
repeated epilation to surgery for mild disease. Many
ophthalmologists and some national trachoma con-
trol programs epilate patients with only a few lashes
touching the eye that do not threaten the cornea.22
The majority of national trachoma control programs
follow the current WHO guideline to offer tarsal
rotation surgery to all patients with TT irrespective of
number of trichiatic lashes, their location, or the
severity of entropion.148 The reality is that patients
with mild disease tend to defer surgery until they are
more symptomatic, preferring to continue to epilate.
2. Lash Follicle Destruction Procedures
Procedures to destroy eyelash follicles are used
regularly in settings where well-developed ophthalmic
services are available and are attractive options in
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metaplastic lashes touching the eye in the absence of
entropion.127 Cryosurgery, electro-epilation, argon
laser photocoagulation, and even radiotherapy have
been used to ablate lash follicles. Reports of these
treatments have generally been small case series with
widely varrying outcomes. The variation may be
attributed to the number, duration, and power of
treatments; disease severity; and the surgeon’s ability
and equipment. Concerns have also been raised about
whether these treatments can provoke or exacerbate
the inflammatory process in patients with TT and
perhaps even cause the development of trichiasis
adjacent to the treatment area.107,143 Additionally, the
need for expensive equipment and a consistent
electricity supply limit their use in trachoma-endemic
areas.a. Cryotherapy
The aim of cryotherapy (cryosurgery) is to destroy
follicles producing aberrant eyelashes by freezing. It
was first considered as a treatment option after
permanent lash loss was noted as a complication of
cryotherapy of eyelid tumors.16,152 The procedure
requires local anaesthesia and a shield to protect the
globe. The cryoprobe (e.g., retinal or Collin’s) uses
nitrous oxide as the cooling agent. It is placed over
the bases of the aberrant lashes. Two cycles of
freezing to --20C for 20--30 seconds and thawing for
1--2 minutes are carried out through either the
conjunctiva or skin. Liquid nitrogen has also been
used, but may cause more severe complications
unless a very targeted nitrogen spray jet is used.89
The lashes are then easily epilated.
Early studies of cryotherapy used a large diameter
probe, which caused some damage to surrounding
tissues resulting in complication rates as high as
38%.39,67,118,143 These included worsening of entro-
pion, lid notching, necrosis, pseudomembrane forma-
tion, symblepheron, depigmentation (of particular
concern inmany trachomaendemic areas), worsening
of dry eye symptoms, and activation of herpes zoster
ophthalmicus. The size of the probe and the site of
application affect the outcome. To improve results,
specially designed lid probes were developed that are
applied to the tarsal conjunctiva and/or the lidmargin
rather than to skin. Permanent trichiasis resolution
occurs in up to 84% of patients, with minimal
complications, including only rare depigmenta-
tion.76,100,109 The optimal length and strength of
treatment and location of treatment (skin, lidmargin,
or conjunctiva) remains uncertain. Furthermore, the
condition specific success rates are unknown as these
case series included trichiasis of various etiologies
including idiopathic (majority), trauma, trachoma,herpes zoster, congenital distichiasis, and lid margin
disease. One trial compared electrolysis (see sub-
sequent section), cryotherapy, and bilamellar tarsal
rotation surgery in patients with TT.106 The re-
searchers found bilamellar tarsal rotation surgery to
have amuchbetter outcome: 80% cure rate compared
with 29% and 18% for electrolysis and cryotherapy,
respectively. These two lash follicle destruction pro-
cedures were limited to one treatment only, however,
which is probably insufficient. In addition to less-
favorable outcomes, cryotherapy requires specialized
equipment that is not available in most settings where
TT treatment is performed.
b. Electrolysis
Electrolysis is widely used to treat trichiasis in settings
with well-established ophthalmic services, usually for
cases with relatively few metaplastic lashes and no
entropion. A fine needle is passed undermagnification
along the side of the shaft of aberrant lashes into the
follicle to a depth of approximately 2.5 mm. A low-
power alternating current delivered through a metallic
resistor produces heat, which destroys the follicle.17,51
The lash is then removed. High recurrence rates have
been described from electro-epilation,106 but electro-
epilation equipment has evolved considerably in recent
years and now allows accurate targeting of individual
lash follicles with minimal collateral damage.73 A non-
concurrent prospective study compared electro-
epilation and tarsal rotation surgery in 744 cases in
Oman (603 patients followed up). A recurrence rate of
51% was found after a single electro-epilation treat-
ment, compared to62%with surgery (relative risk, 1.22;
95% confidence interval [CI], 1.06--1.41; p value not
stated).82 Unfortunately the baseline severity was not
reported for these patients; but it is probable that
electro-epilation was carried out on patients with less
severedisease than thosewhounderwent tarsal rotation
surgery, making direct comparison impossible.
Radiosurgery is similar to electroysis. Heat is
generated by converting alternating current to
direct current in the radiofrequency range of the
electromagnetic spectrum, using an instrument
such as an Ellman Surgitron.81
c. Laser
Argon laser (488--515 nm) is absorbed by mela-
nin, which converts the energy into heat and burns
nearby tissue.77 Argon laser has been used to destroy
lash follicles in patients with trichiasis with success
rates ranging from 28--89%.4,18,72,99,129,149 A power
of 1.0--2.5 watts, for 0.2--0.5 seconds in a spot size of
50--100 mm, is used to create a crater deep enough to
burn the follicle. Multiple treatments are required,
but only minor complications such as dimpling and
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of the histopathological changes in rabbit eyelids
following treatment with either cryosurgery, electro-
epilation or argon laser, the laser produced the most
targeted follicle destruction.12
d. Radiotherapy
Similar to cryotherapy, the treatment of trichiasis
with radiation resulted from the observation of
permanent lash alopecia complicating eyelid tumor
irradiation.37,97 External beam radiotherapy has only
occasionally been used for treating TT.66 It has also
been tested in rabbits to assess the dosage required to
produce lashalopecia.66Topical anaesthetic is required
and a thin strip of lead is placed under the eyelid
to protect the globe. Multiple irradiations of around
300--600 rad each, to a total of approximately 4,000 rad,
are required. This treatment cannot be directed at
individual lashes. Multiple complications have been
described in reports of irradiation of lid tumors,
including conjunctival leukoplakic plaques, scarring
and atrophy of the lid, telangiectasis, ectropion,
temporary erythema, and dermatitis.37,54,66,84,91,97 It is
unlikely to be acceptable to most patients,and is not
suitable for trachoma endemic settings.
3. Surgical Excision of Aberrant Lash-bearing
Follicles or Tissue
Full thickness wedge resections of the affected area
are rarely used since the development of less radical
tarsotomy procedures. Procedures have been de-
scribed to surgically remove individual follicles in
cases of trichiasis without entropion. The aberrant
follicles are accessed either posteriorly through the
conjunctiva of an everted lid or anteriorly through the
tarsus, which is exposed with a gray line split. A vertical
incision is then made through the tarsus along the
shaft of the follicle until the lash root bulb is identified,
which can then be electrolyzed or cauterized under
direct visualization with minimal collateral damage.
These procedures require high magnification, are
time-consuming and technically challenging, and
there are no comparisons of outcomes with other
treatments in the literature.36,142
B. CORRECTIVE LID SURGERY
Surgery to correct TT is a key component of all
trachoma blindness control programs in endemic
countries. Many techniques have been used. In most
the principle is to mobilize the entropic component
of the eyelid, then reposition and suture this in
a correct orientation to prevent eyelashes scratching
the cornea. Tarsal rotation procedures are the most
widely used in endemic countries. Some subtle
variations in these procedures have developed.Otherprocedures are rarely used in endemic settings and
are usually only performed by ophthalmologists.
1. Tarsal Rotation Procedures
a. Bilamellar Tarsal Rotation
The bilamellar tarsal rotation (BLTR; Fig. 3) is very
similar to the Weiss procedure used for entropion of
the lower lid and was first described by Ballen as
a treatment for upper lid entropion.8,139 In BLTR the
lid margin is usually held with hemostats at its medial
and lateral ends, or with sutures running through the
lid just lateral to the punctum and just medial to the
angle. A corneal shield is placed behind the lid.
Specially designed lid clamps that indicate where to
make the horizontal incision have been developed to
provide improved hemostasis and a more standard-
ized placement of the incision.59,75,77,131 A full
thickness incision is made through the skin, 3 mm
above and parallel to the lid margin for a length of
about 20 mm (Fig. 3).8,104,139 The WHO TT surgery
manual states that the incision should bemade in two
stages: first through the anterior lamella and second,
after everting the lid, through the posterior lamella to
meet the first.104 Others have suggested staggering
the two components, with the anterior lamellar
incision being 4 mm from the lid margin and the
posterior lamellar incision being 2.5 mm from the
margin.111 A further variation is to make a second
horizontal tarsal plate incision in the superior tarsus,
to form a bipediculed tarso-conjunctival bridge
completely free from Mu¨ller muscle.15 Three hori-
zontal mattress sutures are inserted that run from the
tarsal conjunctiva of the proximal lid fragment,
through the anterior lamella component of the distal
fragment, to emerge just above the lash line. When
these sutures are tightened and tied, the distal
fragment of the eyelid is held in an everted position.
Silk (4-0) is the most widely used suture material and
must be removed at 7--10 days postoperatively.
Polyglactin-910 (Vicryl) (5-0) has been shown to be
equally effective and can be left to dissolve in situ. 102a
The external wound is usually closed with skin
sutures.
b. Posterior Lamellar Tarsal Rotation
There are several operations that combine tarsot-
omy (incision of conjunctiva and tarsal plate) with
everting sutures.62,63,147 As a group these are usually
referred to as posterior lamellar tarsal rotation (PLTR)
procedures (Fig. 4). They vary in their degree of
dissection of the anterior and posterior lamellae and
in the positioning of the everting sutures. They are
performed with the lid in an everted position, usually
rotated over a lid plate (Trabut type). A horizontal
incision is made through the posterior lamella
Fig. 3. Bilamellar tarsal rotation: A: Bilamellar incision. B: Horizontal mattress suture. C: Postoperative lid eversion.
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to the lid margin. The anterior and posterior lamellae
of the proximal (upper) portion are separated by
blunt dissection between the orbicularis oculi and the
tarsal plate. Similarly, blunt dissection is performed
between the lamellae of the distal portion until the
dark bulbs of the lash follicles just become visible.
Three horizontal everting mattress sutures are passed
through the tarsal conjunctiva and plate of the
proximal portion of the posterior lamella, then
between the divided posterior and anterior parts of
the distal fragment, and finally out through the distal
anterior lamella, emerging through the skin approx-
imately 3 mm above the lid margin. As the sutures are
tightened the proximal segment of the posteriorFig. 4. Posterior lamellar tarsal rotation. A: Posterior lamel
C: Horizontal mattress sutures. D: Postoperative lid eversion.lamella is drawn down and tucks in behind the distal
segment of the posterior lamella and the lid everts.
The degree of eversion, generally ranging from about
90 to 180, is determined by how superior in the
proximal fragment, and how close to the lidmargin of
the distal fragment the sutures are positioned.
A greater degree of external rotation of the distal
fragment can be achieved by two additional short
vertical incisions across the distal portion of the
posterior lamella to the lidmargin. These are done at
both ends and perpendicular to themain incision. In
Kettesy’s PLTR procedure the sutures emerge
through the lid margin and create an approximately
90 rotation.80 In the PLTR procedure described by
Trabut, and widely used in francophone Africanlar incision. B: Dividing anterior and posterior lamellae.
114 Surv Ophthalmol 57 (2) March--April 2012 RAJAK ET ALcountries, the sutures emerge just superior to the lash
line, and thedistal portion is everted through180.126
Other variations of the PLTR include continuous
sutures, mixture of continuous and mattress sutures,
rubber bolsters to tie sutures over, combining PLTR
with a tarsal advance (see subsequent section) and/or
disinsertion of Mu¨ller muscle, and combining poste-
rior tarsal fracture (without dissection between the
lamellae) with a shallow gray line split.42,63,78,93,105,150
2. Tarsal Advance Procedures
a. Tarsal Advance
In the tarsal advance procedure the anterior and
posterior lamellae are separatedby an incision through
the gray line and continued superiorly to the full
height of the tarsal plate: a lamellar division.78 The
tarsal plate is then advanced while the anterior lamella
is retracted. Horizontal mattress sutures running from
the upper fornix to the skin crease, slanting diagonally
downwards, raise the terminal edge of the anterior
lamella in relation to the anterior tarsal surface. The
bare area of anterior tarsal surface produced can be
left to granulate or is covered with buccalmucosa.47,132
An additional vertical incision through skin and
orbicularis about 10 mm from the lateral canthus is
meant to facilitate dissection and advance.90,132 Addi-
tionally, there may be fibrosis and shortening of the
levator complex. To release this, the levator complex
can be divided and fibrotic Mu¨ller muscle excised or
recessed to allow increased mobility of the tarsus.77
b. Tarsal Advance and Rotation
The tarsal advance and rotation (Collin’s modifi-
cation of the Trabut procedure) is a combination of
the posterior lamellar tarsal rotation and the tarsal
advance (Fig. 5). Unlike the tarsal advance, however,
the anterior and posterior lamellae are separated via
the posterior tarsotomy, rather than via the gray line
incision.45,78 A horizontal mattress suture holds the
posterior lamellar portion in an everted position, and
a second horizontal suture is placed across the lid
running from the upper fornix diagonally down-
wards to emerge through the skin. When tightened,
this second suture raises the anterior lamella.113 The
tarsal advance and rotation is sometimes combined
with dissection of the levator aponeurosis andMu¨ller
muscle off the tarsal plate.78 This procedure is
sometimes used in trachoma endemic settings when
there is a degree of lagophthalmos.
3. Posterior Lamellar Lengthening Procedures
Severe cicatricial entropion is characterized by
marked shortening of the posterior lamella. In order
to achieve lid closure, it is sometimes necessary tolengthen the posterior lamella with grafted tissue. A
number of different graft materials have been used:
nasal septal cartilage, buccal mucosa, palatal mucosa,
donor sclera, contralateral tarsoconjunctiva, and
auricular cartilage (overlaid with a mucous mem-
brane).13,14,33,48,70,110,114,119,122 Typically the proce-
dure involves a posterior tarsotomy, lamellar division,
and suturing of the graft material between distal and
proximal tarsal fragments. The technical complexity
of these procedures precludes their use in trachoma
endemic areas where most TT surgery is performed
by non-ophthalmologists.
4. Anterior Lamellar and Lid Margin Procedures
a. Anterior Lamellar Repositioning
Anterior lamellar repositioning is suitable for mild
upper lid entropion without keratinization of the lid
margin.Ahorizontal incision ismade through the skin
crease to expose the tarsal plate. The anterior lamella
is separated from the tarsal plate inferior to the
incision line, to the level of the lash roots.128 Several
sutures are then passed through the skin 1 or 2 mm
above the lashes, through the tarsal plate a few mm
above the skin bite and then back through the skin,
which when tightened externally rotate the lower end
of the lid. A shallow vertical gray line incision can be
added if a greater degree of eversion is desired. The
procedure can also be combined with excision of
a stripoforbicularis oculi in thehorizontal planeof the
skin incision.71 Anterior lamellar repositioning can
also be combined with aberrant lash follicle excision,
which has been reported to give good outcomes.141
b. Eversion Splinting
Eversion splinting involves a shallow gray line
incision (to a depth of 3 mm) and external rotation
of the distal anterior lamella, which ismaintained with
three sutures. The sutures run from the lid margin up
through the anterior lamella to the tarsal conjunctiva
in the upper fornix and back through the skin 6 mm
above the lid margin. The sutures are usually tied over
a paraffin gauze roll. Some surgeons report low
recurrence rates (2--13%) with eversion splinting.5,140
In the only randomized controlled trial using this
treatment for TT, however, the results were poor (71%
TT recurrence).105 In variations of this procedure,
graft material such as skin, donor sclera, or buccal
mucosalmembrane are sutured into the gray line split
to help maintain the external rotation of the distal
anterior lamella.6,65,116,124,125,130
c. Tarsal Grooving (Tarsal Wedge Resection / Cuenod-
Nataf/ Anterior Tarsotomy)
This operation, which has several forms known by
different names, is a variant of the anterior lamellar
Fig. 5. Tarsal advance and rotation. A: Posterior lamellar incision and division between posterior and anterior lamellae
(arrow indicates 180 rotation of terminal tarsus). B: Rotation and suturing of terminal tarsus, inferior advancement and
suturing of posterior lamella (arrow indicates inferior movement of posterior lamella).
TRACHOMATOUS TRICHIASIS IN ENDEMIC COUNTRIES 115repositioning procedure with a horizontal wedge
resection of the tarsus and usually no dissection of the
anterior lamella from the tarsal plate.38,43,55,71,94,
115,117,121,147 An incision ismade along the skin crease
and a variable amount of excess skin removed. The
tarsal plate is exposed and incised from the anterior
surface, either with two parallel, sloping incisions to
form a V-shaped groove (tarsal grooving) or with
a single incision to fracture the tarsal plate (anterior
tarsotomy). The gray line is usually split and Mu¨ller
musclemay also be disinserted from the upper end of
the tarsal plate. Everting sutures are placed across the
groove and out through the skin. As these are
tightened, the groove closes, everting the lid margin.
The sutures can be tied over a rubber bolster.32 The
procedure has been combined with dissection of the
anterior lamella from the tarsal plate and with
division of the orbital septum from the levator
aponeurosis.45,101 In recent decades this procedure
has mainly been used by the trachoma control
program in Vietnam. Alternative approaches to tarsal
grooving have been described that expose the
anterior tarsal surface by extending the gray line split
to divide the lamellae.1235. Tarsectomy
Tarsectomy, excision of some or all of the tarsal
plate, has been used to treat TT where there is
severe scarring and retraction of the tarsus, often
associated with lagophthalmos.11,64,112 Tarsectomy
has been combined with levator recession to help
overcome severe lid closure defects.20,77 There are
concerns about potential complications (e.g., la-
gophthalmos) of this procedure.VIII. Outcomes of Trachomatous
Trichiasis Treatment
A. TRICHIASIS RECURRENCE
Recurrent trichiasis, usually defined as one ormore
lashes touching the globe in the primary position
of gaze, is the most commonly reported outcome
measure in TTsurgery studies. Recurrence rates from
trachoma endemic regions vary widely, ranging from
7.4% at 1 year to 62% at 3 years (Table 3).1,2,21,29,
30,49,82,92,94,96,103,105,106,138,153,154 Variable follow-up pe-
riods can significantly influence the recurrence rate;
overall, however, there appears to be a consistent
TABLE 3
Studies Examining Recurrence Rates after TT surgery
Author Study Description Results Comments
Part A: BLTR and variants
Khandekar
et al, 200182
Design: non-concurrent prospective
cohort study
Procedure: BLTR
Location: Oman
Number of patients: 292
Number of eyelids: Not stated in paper
Case severity: Major TT
Surgeon grade: not stated
Follow-up period: mean: 3.1 yrs
(range 2--3.5 yrs)
Outcome measure: recurrent TT (1þ lashes)
Follow-up rates: 81% (603/744)
Recurrence rates: 61.8% overall
43.6% Major TT recurrence
18.2% Minor TT recurrence
Associations with recurrence:
 District
 Duration of follow-up
 Infective conjunctivitis at follow-up
Complications: none stated
Electro-epilation for Minor TT also
studied: recurrence rate 50.6%
Alemayehu
et al, 20042
Design: RCT of surgery done by (A)
ophthalmologists vs. (B) IECW
Procedure: BLTR
Location: Ethiopia
Number of patients: 982
Number of eyelids: 1,750
Case severity: Minor and Major TT
Surgeon grade: ophthalmologists and IECW
Follow-up period: 3 months and 6 months
Outcome measure: recurrent TT (1þ lashes)
Follow-up rates: 77% at 6 months
Recurrence rates:
 By person: 14.3% (124/865) by 6 months
 By eye: 9.0% (140/1553) by 6 months
 Arm A: 12.7% (47/370) of people at
3 months
 Arm B: 9.9% (34/343) of people at
3 months
Associations with recurrence: baseline severity
Complications:
 Granulomas: 14% (100/713)
 Lid contour abnormality: 6.2% (44/713)
No significant difference in TT
recurrence rates found between
ophthalmologists and IECW.
Leading study supporting the
use of non-ophthalmologists in
the provision of TT surgery services.
Zhang
et al, 2004154
Design: Prospective case-control cohort study
Procedure: BLTR
Location: Nepal
Number of patients: 78
Number of eyelids: 79
Case severity: Minor and Major TT
Surgeon grade: not recorded
Follow-up period: 12 months
Outcome measure: recurrent TT (1þ lash)
Follow-up rates: 56% at 12 months
Recurrence rates: 25% (11/44)
Associations with recurrence:
 Presence of C. trachomatis
 O5 trichiatic lashes at baseline
 TI or TF
Complications: none
Merbs et al, 200592;
West et al, 2005134,a
Design: Retrospective cohort study
Procedure: BLTR
Location: Tanzania
Number of patients: 384
Number of eyelids: 630
Case severity: not recorded
Follow-up rates: 64% (384/601)
Recurrence rates: 27.9% (176/630)
Associations with recurrence:
 District
 TI in the surgical eye
116
Su
rv
O
p
h
th
alm
o
l
57
(2)
M
arch
--A
p
ril
2012
R
A
JA
K
E
T
A
L
Surgeon grade: not recorded
Follow-up period: variable. All O18/12
Outcome measure: recurrent TT (1þ lash or
evidence of epilation)
 2 or more household members with TI
 Older age
 O1 child in house with C.trachomatis
infection
 Left eye
Complications: none recorded
El Toukhy
et al, 200649
Design: Prospective observational
Procedure: BLTR
Location: Egypt
Number of patients: 493
Number of eyelids: 638
Case severity: Minor and Major TT
Surgeon grade: ophthalmologist
Follow-up period: 8--10 weeks
Outcome measure: surgical failure (1þ lash)
Follow-up rates: 94% (599/638)
Recurrence rates: 16.4% (98/599)
Associations with recurrence:
 Pre-operative corneal opacity
 Pre-operative corneal staining
 Use of silk sutures (rather than Vicryl)
 Use of four or more sutures
Complications: none recorded
Zhang
et al, 2006153
Design: RCT of post-op treatment (A)
azithromycin vs. (B) placebo
Procedure: BLTR
Location: Nepal
Number of patients: 109
Number of eyelids: 148
Case severity: Minor and Major TT
Surgeon grade: ophthalmologist
Follow-up period:12 months
Outcome measure: recurrent TT (1þ lash or
evidence of epilation)
Follow-up rates: 78% (116/148)
Recurrence rates: 29% (33/114) at 12 months
Associations with recurrence:
 Major TT at baseline associated with re-
currence at 3 months
 Placebo post-operatively in patients with
Major TT at baseline
Complications: none recorded
There was no significant difference
in the overall recurrence rate by
treatment arm. For eyes which had
Major TT pre-operatively, there was
significantly less recurrence in the
azithromycin arm at 12 months (21%
azithromycin, 62% placebo, p50.030)
West et al, 2006138;
Gower et al, 201060,a
Design: RCT of postoperative (A) oral
azithromycin (B) oral azithromycin for patient
and family members (C) topical TTC
Procedure: BLTR
Location: Ethiopia
Number of patients: 1,452
Number of eyelids: 1,452 (bilateral TT: 1 eye
randomly selected)
Case severity: Minor and Major TT
Surgeon grade: IECW
Follow-up period: 12 months
Outcome measure: recurrent TT (1þ lash or
evidence of epilation)
Follow-up rates: 97% (1414/1452) patients
Recurrence rates: 7.6% (107/1414) overall
(A) 5.5% (26/472), (B) 7.6% (36/472),
(C) 9.6% 45/470)
Associations with recurrence:
 Male sex
 Moderate/severe pre-operative entropion
 No azithromycin treatment
 Incision ! 22 mm
Complications:
 Granuloma: 10.5%
 Lid contour abnormalities: 1.2%
The incidence of recurrence was lower in the
azithromycin group (A þ B) compared to the
topical tetracycline group (C): 6.9/100 person-
years vs 10.3/100 person-years (P 5 0.047),
respectively. However C.
trachomatis not a risk factor
for recurrence.
Part B: PLTR and variants
Halasa and Jarudi,
197463
Design: retrospective case series
Procedure: PLTR with rubber bolster
Follow-up rates: retrospective
Recurrence rates: 3.3% ‘‘severe enough to
(continued on next page)
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TABLE 3
Continued
Author Study Description Results Comments
Location: USA
Number of patients: 154
Number of eyelids: 300
Case severity: not stated
Surgeon grade: not stated
Follow-up period: minimum: 6 months,
maximum: 9 years
Outcome measure: ‘‘recurrence’’
necessitate re-operation’’(10/300). Overall
TT recurrence rate not stated.
Associations with recurrence: none recorded
Complications: none
Bog et al, 199321 Design: prospective cohort study
Procedure: PLTR
Location: Tanzania
Number of patients: 94
Number of eyelids: 156
Case severity: Major TT
Surgeon grade: ophthalmic nurse
Follow-up period: 9--36 months (mean 25.5
months)
Outcome measure: recurrent TT (1þ lash)
Follow-up rates: 91% (86/94) patients
Recurrence rates: 17.4% (25/144) lids
Associations with recurrence: none recorded
Complications:
 6.3% (9/144) notching
 0.7% (1/144) infection
Yeung et al, 1997150 Design: not stated
Procedure: posterior tarsal fracture þ shallow
gray line split
Location: Hong Kong
Number of patients: 19
Number of eyelids: 24 (20 trachomatous
aetiology)
Case severity: not stated
Surgeon grade: not stated
Follow-up period: 2--12 months (mean 6.3)
Outcome measure: recurrent trichiasis
(1þ lashes)
Follow-up rates: 100% (24/24)
Recurrence rates: 35% (9/24)
Associations with recurrence: none recorded
Complications: 4.2% (1/24): lid closure defect
Bowman
et al, 200024a
Design: retrospective cross sectional
Procedure: PLTR
Location: Gambia
Number of patients: 65
Number of eyelids: 115
Case severity: Major TT
Surgeon grade: ‘‘Medical staff’’ and ‘‘Senior
ophthalmic assistants’’
Follow-up period: median:7 (range not stated)
Outcome measure: recurrent TT (1þ lash)
Follow-up rates: retrospective study
Recurrence rates:
 55% (63/115) eyes
 65% (42/65) people
Associations with recurrence: none recorded
Complications: 3.5% (4/115) lagophthalmos
Long term recurrence rates can
be very high.
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Bowman
et al, 200223
Design: prospective cohort study
Procedure: PLTR
Location: Gambia
Number of patients: 34
Number of eyelids: 54
Case severity: Major TT
Surgeon grade: ophthalmic nurse
Follow-up period: 12 months
Outcome measure: number of trichiatic lashes at
12 months F/U
Follow-up rates: 98% (53/54)
Recurrence rates: 28% (15/53). Comprising:
 9% (5/53) Major TT recurrence
 19% (9/53) Minor TT recurrence
Associations with recurrence: none recorded
Complications:
 9.4% (8/53) granuloma
 3.8% (2/53) lid notching
 1.9% (1/53) ptosis
Although recurrence rates can be
high, this study identified, that
64% (9/14) of the recurrences
had !6 lashes.
Burton et al, 200529 Design: prospective cohort study
Procedure: PLTR
Location: Gambia
Number of patients: 162
Number of eyelids: 214
Case severity: not stated
Surgeon grade: ophthalmic nurse
Follow-up period: 36-48 months
Outcome measure: recurrent TT (1þlash)
Follow-up rates: 87% (141/162)
Recurrence rates: 41.6% (89/214) lids (52/
214)
Comprising:
 24.3% (52/214) Major TT recurrence
 17.3% (37/214) Minor TT recurrence
Associations with recurrence:
 Conjunctival bacterial infection
 Papillary inflammation (P2/P3)
Complications: none recorded
Burton et al,
2005 (1)30;
Rajak et al,
2010 (2)103
Design:
(1) RCT of postoperative (A) azithromycin
vs. (B) TTC
(2) Prospective cohort study
Procedure: PLTR
Location: Gambia
Number of patients: 451
Number of eyelids:
Case severity: Major TT
Surgeon grade: ophthalmic nurse
Follow-up period:
RCT: 12 months
Prospective cohort study: 4 years
Outcome measure: recurrent TT (1þ lash)
Follow-up rates:
(1) 94.4% (426/451)
(2) 74.7% (266/365)
Recurrence rates
(1) 12 months: 41.3% (176/451)
 Arm A: 41.2% (84/204)
 Arm B: 41.4% (92/222)
(2) 4 years (arms A&B combined): 41% (110/
266)
Associations with recurrence:
(1) 12 months
 O10 trichiatic lashes pre-operatively
 Severe conjunctival inflammation
(P3) at f/u
 Conjunctival bacterial infection at f/u
 Surgeon
(2) 4 years
 O10 trichiatic lashes pre-operatively
 Moderate/severe conjunctival inflamma-
tion (P2/33) at 4 years
Complications (12 months):
 0.44% (2/451) defective lid closure
 0.22% (1/451) lid infection
No significant difference in
post-operative recurrence for
azithromycin and TTC
Wide variation in recurrence rates
of different surgeons.
The recurrence rate does not increase
from one year to four years
post-operatively
(continued on next page)
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TABLE 3
Continued
Author Study Description Results Comments
Part C: Posterior lamella lengthening
Hosni, 197470 Design: not stated
Procedure: posterior lamella lengthening with
buccal graft
Location: Egypt
Number of patients: 708
Number of eyelids: 426
Case severity: ‘‘trachomatous entropion
trichiasis’’
Surgeon grade: not stated
Follow-up period: not stated
Outcome measure: recurrent TT (1þ lashes)
Follow-up rates: 100%
Recurrence rates: 10.0% (71/708) overall,
comprising: 4.0% (28/708) Minor and 6.1%
(43/708) Major recurrence
Associations with recurrence: not recorded
Complications: none
Part D: Tarsal grooving and variants
Prachakvej
et al, 1978101
Design: retrospective case series
Procedure: tarsal grooving þ division of orbital
septum from levator aponeurosis
Location: Thailand
Number of patients: 24
Number of eyelids: 35
Case severity: ‘‘advanced trachomatous
entropion’’
Surgeon grade: not stated
Follow-up period: not stated
Outcome measure: not stated
Follow-up rates: 100%
Recurrence rates: ‘‘undercorrection’’:
5.7% (2/35)
Associations with recurrence: none recorded
Complications: overcorrection: 2.9% (1/35)
Thanh et al, 2004123;
Khandekar
et al, 200982a,a
Design: prospective cohort study
Procedure: Cuenod-Nataf
Location: Vietnam
Number of patients: 472
Number of eyelids: 648
Case severity: any TT
Surgeon grade: ophthalmologist
Follow-up period: 24 months
Outcome measure: 1þ trichiatic lashes
Follow-up rates: 96% (453/472)
Recurrence rates: 15.9% (101/636)
Associations with recurrence:
 Age O70
 Female
 Surgeon
 District
 History of previous TT surgery
 Severe conjunctival scarring
 Post-op adjustments made to suture ten-
sion
Complications: none recorded
Part E: Eversion splinting
Win, 1976140 Design: not stated
Procedure: gray line split
Follow-up rates: 28% (528/1561)
Recurrence rates: 8/528 (2%)
Very low f/u rate: difficult to draw
conclusions on gray line
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Location: Burma
Number of patients: not stated
Number of eyelids: 1861
Case severity (author’s grading system):
 128/528 grade I (TT of half length of lid
margin, lid soft)
 272/528 grade II (TTof whole length of lid
margin, lid soft)
 128/528 grade III (TT of whole length of
lid margin, lid hard)
Surgeon grade: not stated
Follow-up period: 12 months
Outcome measure: not stated
Associations with recurrence: severe pre-op TT
Complications: none recorded
split technique
Thommy, 1980124 Design: prospective cohort
Procedure: gray line split with auto-skin graft in
incision
Location: Nigeria
Number of patients: 200
Number of eyelids: 341
Case severity: not stated
Surgeon grade: not stated
Follow-up period: minimum: 4 months,
maximum: 2 years
Outcome measure: ‘‘entropion or misdirected
lashes’’
Follow-up rates: 93.8% (320/341)
Recurrence rates: 6.6% (21/320)
Associations with recurrence: none recorded
Complications: none recorded
Thommy, 1981125 Design: not stated
Procedure: gray line split with scleral graft in
incision
Location: Nigeria
Number of patients: 136
Number of eyelids: 155
Case severity: not stated
Surgeon grade: not stated
Follow-up period: minimum: 2 months,
maximum: 15 months
Outcome measure: ‘‘trichiasis’’
Follow-up rates: not stated, implies 100%
Recurrence rates: 7.7% (12/155)
Associations with recurrence:
Complications:
 Granuloma: 10.3% (16/155)
 Partial sloughing of scleral strip: 2.6% (4/
155)
Part F: Tarsectomy
Jones et al, 197677 Design: prospective cohort
Procedure: tarsectomy
Location: Iran
Number of patients: not stated
Number of eyelids: 36
Case severity: severe entropion
Follow-up rates: 83.3% (33/36)
Recurrence rates: 15.2% (5/33)
Associations with recurrence: none recorded
Complications: high lid arch: 18.2% (6.33)
(continued on next page)
T
R
A
C
H
O
M
A
T
O
U
S
T
R
IC
H
IA
S
IS
IN
E
N
D
E
M
IC
C
O
U
N
T
R
IE
S
121
TABLE 3
Continued
Author Study Description Results Comments
Surgeon grade: not stated
Follow-up period: 12 months
Outcome measure: entropion, ‘‘few aberrant
lashes’’
Part G: O1 procedure
Kemp and Collin,
198678
Design: retrospective case series
Procedure:
1. Anterior lamella repositioning þ/ gray
line split: for minimal entropion
2. Anterior lamella repositioning þ gray line
split þ tarsal wedge resection or lamellar
division: for moderate entropion
3. Tarsal advance and rotation or posterior
lamellar lengthening procedure: for severe
entropion
Follow-up rates: retrospective study
Recurrence rates:
1. Minimal entropion: 31.9% (30/94)
2. Moderate entropion: 26.5% (13/49)
3. Severe entropion: 25% (10/40)
Associations with recurrence: none recorded
Complications: none recorded
Location: UK
Number of patients: 107
Number of eyelids: 183
Case severity: not stated. 40.6% TT (73/180)
Surgeon grade: oculoplastic surgeon
Follow-up period: Mean 3 years, minimum 10
months
Outcome measure: need for further surgery
Babalola, 19886 Design: probable retrospective case series
Procedure:
1. BLTR
2. Gray line split with scleral graft in incision
Location: Nigeria
Number of patients: not stated
Number of eyelids:
1. 31
2. 23
Case severity: not stated
Surgeon grade: not stated
Follow-up period: not stated
Outcome measure: not stated
Follow-up rates: 100%
Recurrence rates:
1. 22.6% (7/31)
2. 26.1% (6/23)
Associations with recurrence: none recorded
Complications:
1. BLTR
Granuloma: 9.7% (3/31)
Infection: 3.2% (1/31)
2. Gray line split/scleral graft
Graft sloughing/rejection: 30.4% (7/23)
Infection: 4.3% (1/23)
Secondary hemorrhage: 4.3% (1/23)
Nasr, 198994 Design: retrospective case series
Procedure:
1. Anterior tarsotomy: for mild to moderate
entropion
Follow-up rates:
1. Not stated
2. 92.8% (464/500) PLTR cases
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2. PLTRþ/ auricular or scleral graft: for
moderate to severe entropion
3. Anterior lamellar recession þ mucus
membrane graft for severe entropion with
irregular eyelid margin
Location: Saudi Arabia
Number of patients: 960
Number of eyelids: not stated
Case severity: All entropion severity
Surgeon grade: ophthalmologist
Follow-up period: average 22.5 months
(range not stated)
Outcome measure: not stated
3. Not stated
Recurrence rates (‘‘success [not defined]
rates’’):
1. Denominator not stated
2. 11.6% (54/464)
3. c.50% (exact figure not stated)
Associations with recurrence: severe pre-op
entropion
Complications: none recorded
Reacher et al, 1990105 Design: RCT of 5 surgical techniques (see below)
Procedure:
(A) BLTR
(B) Tarsal advance and rotation
(C) Eversion splinting
(D) Tarsal advance
(E) Tarsal grooving
Location: Oman
Number of patients: 165
Number of eyelids: 165 (bilateral TT: 1 eye
selected for trial)
Case severity: Major TT
Surgeon grade: not stated
Follow-up period: average 7.9 months (range:
5--11 months)
Outcome measure: recurrent TT (1þ lashes)
Follow-up rates: 92.7% (153/165)
Recurrence rates:
(A) 25.6% (10/39)
(B) 50.0% (11/22)
(C) 66.7% (14/21)
(D) 44.7% (17/38)
(E) 87.9% (29/33)
Associations with recurrence: none recorded
Complications: defective lid closure
The first RCT of surgical
techniques in the field.
Reacher et al, 1992106 Design: RCT of 3 procedures for Minor TT and 2
surgical techniques for Major TT
Procedure:
1. Minor TT
(A) Electrolysis
(B) Cryoablation
(C) BLTR
2. Major TT
(A) BLTR
(B) TA&R
Location: Oman
Number of patients: 357
Number of eyelids: 384 (bilateral TT: 1 eye
selected for trial)
Follow-up rates: 94% of lids seen at either/
both 9- and 21-month follow-ups
Recurrence rates:
1. Minor TT
(A) 52.6% (30/57)
(B) 71.9% (41/57)
(C) 11.5% (6/52)
2. Major TT
(A) 18.4% (18/98)
(B) 45.5% (46/101)
Associations with recurrence: none recorded
Complications:
Granuloma
12.6% (19/151) of BLTR
Led to The WHO endorsing
BLTR for all TT surgery
(continued on next page)
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TABLE 3
Continued
Author Study Description Results Comments
Case severity: Minor and Major TT
Surgeon grade: not stated
Follow-up period: 9-21 months
Outcome measure: recurrent TT (1þ lashes)
Poor cosmetic result (ectropion)
5% (5/101) of TA&R
2% (2/98) of BLTR
Immediate post-op haemorrhage
1.6% 2/129 TA&R
Overcorrection requiring revision
1.3% (2/151) BLTR
Defective lid closure:
1% (1/101) of TA&R
Negrel et al, 200096 Design: retrospective case series of random
sample
Procedure:
1. BLTR (91%)
2. PLTR (9%)
Location: Morocco
Number of patients: 740
Number of eyelids: 740
Case severity: All TT
Surgeon grade: Ophthalmologists, general
doctors, and nurses
Follow-up period: All O6 months
Outcome measure: recurrent TT (1þ lashes)
Follow-up rates: retrospective study
Recurrence rates: 15.8% (117/740)
Associations with recurrence: none recorded
Complications:
 Overcorrection: 2.3% (17/740)
 Ptosis: 0.4% (3/740)
 Lid necrosis without corneal exposure:
3.6% (27/740)
 Lid necrosis with corneal exposure: 0.14%
(1/740)
 Granuloma: 0.95% (7/740)
Adamu et al, 20021 Design: RCT of surgical techniques
Procedure: (A) BLTR vs. (B) PLTR
Location: Ethiopia
Number of patients: 153
Number of eyelids: 256 (BLTR: 124, PLTR: 132)
Case severity: All TT
Surgeon grade: ophthalmologist
Follow-up period: 3 months
Outcome measure: recurrent TT (1þ lashes)
Follow-up rates: 92% (141/153) patients
Recurrence rates:
(A) 10.4%
(B) 12.3%
Associations with recurrence: none recorded
Complications:
 3.48% (4/115) over-correction in BLTR
 1.61% (2/124) post-op bleeding in BLTR
 0.81% (1/124) post-op infection in BLTR
 Notching and granuloma occurred more
frequently in BLTR than PLTR (data not
given)
The only randomized comparison
of the two most widely used
procedures. It found no significant
difference in recurrence rates for
Minor (p50.686, OR and C.I.
not stated) or Major (p50.286
OR and C.I. not stated) TT.
Dhaliwal et al, 200445 Design: RCT of three surgical techniques
Procedure:
(A) PLTR (Kettesy)
(B) Tarsal advance and rotation variant
(C) Tarsal grooving variant
Location: India
Follow-up rates: 96.7% (87/90)
Recurrence rates:
(A) 0% (0/28)
(B) 6.9% (2/29)
(C) 3.3% (1/30)
Associations with recurrence: none recorded
Procedures
(A) No dissection between ant.
and post. lamellae of proximal
portion in PLTR. Sutures
emerge inferior to lash line.
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TRACHOMATOUS TRICHIASIS IN ENDEMIC COUNTRIES 125pattern. There is an early peak within the first 3 to 6
months, probably the result of surgery-related factors
causing the lid to be incompletely rotated and also to
wound healing. This is then followed by an accumu-
lation of later recurrence that may be caused by
entropion and new metaplastic changes from pro-
gressive cicatricial disease.30,103
Multiple risk factors for trichiasis recurrence have
been identified, broadly divided into surgeon and
surgery related and patient specific. Although some
factors, such as pre-operative disease severity, have
repeatedly been shown to affect outcome, others are
identified on single, usually cross-sectional analyses
and require further investigation.
1. Surgery and Surgeon-related Factors
a. Surgical Procedure
The choice of surgical technique is critical. In
trachoma-endemic countries surgery is primarily
performed by nurses or eye-care workers who have
received short, intensive training in a single surgical
procedure. This procedure must be both simple to
execute and have low recurrence rates. Three
randomized trials have compared procedures in
these settings (Table 3, part G). The first study
randomly allocated 165 patients with major TT (O5
trichiatic lashes) to one of five different proce-
dures.105 It found a recurrence rate of 29% in BLTR,
54% in tarsal advance and rotation, 71% in eversion
splinting, 73% in tarsal advance, and 89% in tarsal
grooving. The number of procedures in each group
was small, and therefore confidence intervals for
recurrence rates wide, but BLTR was found to have
significantly less recurrence than eversion splinting
(p ! 0.01), tarsal advance (p ! 0.001), and tarsal
grooving (p! 0.01), but not less than tarsal advance
and rotation. The second study randomly allocated
200 eyelids with major TT without lagophthalmos to
either BLTR or tarsal advance and rotation.106 BLTR
had significantly less recurrence than tarsal advance
and rotation (relative hazard, 3.1; 95% CI, 1.9--5.2; p
value not stated). The third study followed up 237
eyelids (92.6% of those operated on) that had been
randomly allocated to either BLTR or PLTR three
months after surgery.1 There was no statistically
significant difference in recurrence rate between
the two procedures (BLTR recurrence, 3/29 [10%];
PLTR recurrence, 2/41 [5%]; p 5 0.686) and major
trichiasis (BLTR recurrence, 9/86 [10%]; PLTR
recurrence, 2/41 [16%]; p5 0.286).
Numerous case series and retrospective reviews
have reported on the different procedures. The
results of these reports are included in Table 3. They
frequently present exceptional results, which are
often better than the results of the randomized
126 Surv Ophthalmol 57 (2) March--April 2012 RAJAK ET ALcontrolled trials discussed herein. These procedures,
however, have usually been carried out in hospitals by
ophthalmologists and are often subject to selection
bias and follow-up bias.
b. The Surgeon
The surgeon’s technical ability is critical in de-
termining results. Surgeon-specific TTrecurrence rates
ranged from 0--83% in one study in Gambia.30 Other
studies have identified significant differences in re-
currence rates in different districts, which may also
reflect variations in surgeon ability.82,134 Although
a uniform surgical procedure has been used by all
surgeons in each of these studies, subtle differences in
incision lengthandplacementandsuture tightnessmay
have made substantial differences to the outcome.
Incision length has been studied: The recurrence rate
at 6weeks post-BLTR surgery is significantly higher with
an incision length !22 mm (crude odds ratio [OR],
3.58; 95% CI, 1.39--9.23).60 However, short incisions
may be a confounder for small eyelids, which may have
higher recurrence rates as the surgery can be more
difficult. Left eyelid surgery has been reported to have
a higher recurrence rate (32%) than right lid surgery
(25%; OR 1.5; 95% CI, 1.0--2.1; p 5 0.05), suggesting
that left eye surgery is harder for right-handed surgeons
and further emphasising the importance of operative
technique.92 The inter-surgeon variation highlights the
need to audit results, supervise surgeons, and retrain
where necessary.
c. Other Factors
Other surgical factors which have been associated
with recurrent TT but require further investigation
include the type of suture material used,49 the use of
more than three sutures,49 and the need to make
postoperative adjustments to the sutures.123
2. Patient-specific Factors
a. Pre-operative Disease Severity and Recurrent Disease
Severe pre-operative disease has consistently been
observed to be a risk factor for postoperative TT
recurrence.2,29,30,94,103,133,138,140,153,154 This may be ex-
plained by the shorter, more scarred posterior lamella
in severe disease producing residual entropic forces
after surgery, andby the increased technical difficulty of
operating on such lids.
Similarly, repeat TTsurgery is associatedwithhigher
recurrence rates. These lids are already self-selected as
having had more severe TT surgery at baseline, and
repeat surgery is often more challenging as the tissue
planes are distorted and scarred.106,123
b. Infection
The role of C. trachomatis infection in recurrent
trichiasis remains uncertain.35 Some studies foundan association between C.trachomatis infection or
living with children with active infections and
recurrent trichiasis, whereas others did
not.30,134,154 Three studies have assessed the effect
of postoperative azithromycin treatment on TT
recurrence. One of these found a modest effect
and two showed no effect.30,138,153 The different
outcomes may have resulted from the different
settings in which the trials were conducted. The
study that found a beneficial effect was conducted in
a high-prevalence setting (Ethiopia), and the others
were not (Gambia and Nepal). The observed
beneficial effect on surgical outcome reported in
the Ethiopian study does not appear to be explained
by differences in C. trachomatis infection rates
resulting from treatment.138 It is possible that
azithromycin reduces the load of non-chlamydial
bacteria, which may drive chronic tarsal inflamma-
tion and scarring, or the anti-inflammatory proper-
ties of azithromycin may reduce scarring.
Non-chlamydial conjunctival bacterial infection
has been associated with higher rates of recurrence
and postoperative inflammation,29,103 but it is not
known whether this infection drives the scarring
process. Infection has been associated with in-
creased expression of potentially important media-
tors in the scarring process.26,28
c. Other Factors
Several other factors have been associated with TT
recurrence: older age29,30,106,123,134 (which may be
a confounder for more severe disease), female
sex,106,138 and persistent severe conjunctival
inflammation.30,134
B. VISUAL ACUITY AND CORNEAL OPACITY
Trachomatous visual impairment and blindness,
which result from corneal opacification, have
generally been thought of as irreversible. Corneal
transplantation is rarely available in trachoma-
endemic countries, and the results have been
disappointing. One case series reported graft re-
jection in 4 of 7 penetrating keratoplasties per-
formed for trachomatous corneal opacity.151
Another reported successful results from ipsilateral
kerato-rotation.19 As cataract extraction was per-
formed simultaneously, the improvement in visual
acuity is difficult to interpret. Additionally, this sort
of highly specialized procedure is not suitable for
trachoma-endemic regions. Despite this discourag-
ing background, several recent studies have shown
modest improvement in visual acuity following
trichiasis surgery—about one LogMAR line of
acuity.30,106,144 This may be the result of a reduction
in epiphora and photophobia, an improvement in
Fig. 6. A: Post-operative granuloma. B: Post-operative
wound infection C: Postoperative lid notching.
TRACHOMATOUS TRICHIASIS IN ENDEMIC COUNTRIES 127the quality of the tear film, the resolution of corneal
epithelial damage, or a gradual fading of milder
corneal scars. Conversely in some patients, the
corneal opacity develops or progresses despite
successful trichiasis surgery.30 The reasons for this
are not well understood, but may involve conjunc-
tival inflammation, keratinisation, dry eye, or
secondary bacterial infection.
C. SURGICAL COMPLICATIONS
Serious complications are fortunately relatively
rare in TT surgery, even when it is performed in
resource-limited settings.
1. Stitch Granulomas
Stitch granulomas (Fig. 6A) have been reported
to occur with most TT surgical techniques and with
the use of both non-absorbable and absorbable
sutures.1,2,6,23,45,60,96,106,125 The highest reported
rates are 14%. These can be quite large—even
obscuring the visual axis.2 The treatment of granu-
lomas vary. Some surgeons leave them in situ to
regress spontaneously, others excise them and
others use steroid drops.79,125 In general, large
granulomas should be removed and smaller ones
may be left if not causing discomfort.
2. Wound Infection
Despite the frequent infection of the conjunctival
sac associated with trichiasis, wound infections are
surprisingly infrequent after TT surgery (Fig. 6B).1,30
Preparing the skin and the conjunctival sac with
a suitable antiseptic solution such as povidone iodine
is very important. Similarly, postoperative topical
antibiotics may also reduce the risk.
3. Lid Notching and Overcorrection
Lid notching occurs when one of the everting
sutures is over-tight, producing an irregular lid
contour (Fig. 6C). Rates as high as 6.3% have been
reported.21 If notching is visible at the end of
surgery, the relevant suture should be adjusted or
replaced. Overcorrection of the whole lid is less
common and may be less noticeable if bilateral. In
the absence of lagophthalmos, mild to moderate
overcorrection can be left, as it tends to settle back
into a more anatomically correct position during the
following months. More severe overcorrection may
require surgical revision.
4. Other Complications
Intra- and postoperative hemorrhage occurs
occasionally, usually when the marginal artery has
been cut. Diathermy is rarely available in trachomaendemic settings, but bleeding can usually be
controlled by prolonged pressure. Serious, uncon-
trollable bleeding is extremely rare in the absence of
other hematological disorder.IX. Treatment of Trachomatous
Trichiasis in Endemic Settings
A. CHOICE OF OPERATION
In the light of the results from the trials described
herein and the relative simplicity of the BLTR
procedure, WHO advocates the use of this operation
for all patients with TT without lagophthalmos in
endemic countries, irrespective of the amount of
128 Surv Ophthalmol 57 (2) March--April 2012 RAJAK ET ALtrichiasis and severity of the entropion.104,148 Various
forms of PLTR are widely used in trachoma-endemic
regions, and this is generally considered an accept-
able alternative. The only direct comparison between
these two techniques showed similar outcomes,
although the surgeries were performed by ophthal-
mologists in a teaching hospital, and there was only
three months of follow-up.1,147
Lid shortening and lagophthalmos are often
found in individuals with severe conjunctival scar-
ring or following previous surgery.77,78 Both the
BLTR and PLTR procedures can cause lid shorten-
ing and are therefore not suitable for eyes with
lagophthalmos. In cases of significant lagophthal-
mos the shortened posterior lamella can be mobi-
lized, allowing it to advance, by recession or release
of the levator and Mu¨ller muscles.77,78 This can be
combined with a Trabut-type operation and is
referred to as the Tarsal Advance and Rotation in
the WHO surgery manual, which recommends its
use in this situation.104 Alternatively, the posterior
lamella can be lengthened using graft material,
although this is rarely available in trachoma-
endemic settings. It remains uncertain which of
the various options for the treatment of trachoma-
related defective lid closure offers the best results.
One trial attempted to compare the Tarsal Advance
and Rotation (with or without levator incision) with
a buccal mucosal membrane graft into the posterior
lamella; unfortunately, there was insufficient
enrollment.106
B. INDICATIONS FOR SURGERY
Currently WHO recommends lid rotation surgery
(BLTR or PLTR) for all patients with TT, irrespective
of severity. There is a broad consensus that surgery is
appropriate for patients with major TT, but for
minor TT and particularly those patients with just
a few peripheral, metaplastic lashes without entro-
pion, practice varies. Many patients and clinicians
prefer to defer surgery and epilate until more
problematic disease develops. The rationale for
the WHO recommendation is that TT patients
may not be seen again; therefore, surgery should
be performed when the opportunity arises.
C. DELIVERING TT SURGERY SERVICES IN
ENDEMIC COUNTRIES
1. Who Should Operate?
As a result of the huge burden of un-operated TT
and the scarcity of ophthalmologists in trachoma-
endemic countries, the vastmajority of surgery is done
by nurses, health-care workers, or integrated eye care
workers (IECWs) with varying degrees of training and
experience. The training course is usually 2--3 weekslong. One study has shown similar recurrence rates
outcomes comparing ophthalmologists and IECWs.2
That study, however, only compared two IECWs with
two ophthalmologists, all of whom had very high
output. Another study has reported the not-
unexpected finding that there is marked variation in
the rates of recurrence between different surgeons.30
Suitably trained health-workers and/or ophthalmolo-
gists can provide TT surgery, but they should be
performing TT surgery regularly and have their
outcomes audited from time to time. Unfortunately,
many TTsurgeons perform only a few procedures per
year.61,86 Surgeons frequently reported having a short-
age of time, as many also manage vaccination pro-
grams, childbirth, and diseases such as tuberculosis,
acquired immune deficiency syndrome, and malaria.
Additionally, many work in rural clinics where health-
system failures prevent them from receiving the
necessary equipment and consumables.61 Further-
more, many trained TT surgeons stop doing TT
surgery altogether; a study from Ethiopia found
a surgeon attrition rate of 59% in the most trachoma-
prevalent region of the country.612. How Should the Service Be Structured?
There are two broad models for TT surgical
provision: health-center-based (‘‘static’’ or ‘‘fixed’’
services) and outreach (‘‘campaign’’). In the health-
center model, TT surgery is integrated into routine
clinical services. The catchment population is
educated about the service and patients are ex-
pected to attend the clinic for assessment and
treatment as required. In the outreach model
a temporary clinic and operating theater are set
up for a short period of time, usually in a rural
setting without pre-existing facilities. The ‘‘cam-
paign’’ is advertised to the local community by
health-care workers, in markets and religious cen-
ters, by radio and word of mouth. There are
advantages and disadvantages to each approach. A
successful static model may be more sustainable in
the long term, but depends on a well-organized
health system that can ensure that the correct
equipment, personnel, and patients are in the clinic
at the same time. The outreach model enables large
numbers of operations to be conducted in a short
period of time, often in locations where patients
have not been able to access TT surgery, but usually
depends on charitable organizations to fund and
organize the service and does not build a sustainable
health system. Studies from Ethiopia and Tanzania
have found that despite training of large numbers of
TT surgeons and provision of equipment for a clinic-
based service, the bulk of the surgery has been
performed in outreach campaigns.61,86 Additionally,
TABLE 4
Barriers to Surgery
Authors Study Description Surgical Uptake Barriers
Courtright, 199440 Design: Prospective cohort
Location: Malawi
Number of participants: 29
Follow up period: 9-12 months
37.9%  Far distance from main road
 Not knowing another woman who had re-
ceived surgery
 Unilateral TT
 Not widowed
West et al, 1994 (1)136;
Oliva et al, 1997 (2)98,a
Design: Prospective cohort
Location: Tanzania
Number of participants: 200
Follow up period:
(1) 2 years and (2) 7 years
18% at 2 years
27.4% at 7 years
 Lack of symptoms
 Lack of time
 Additional costs
 Lack of escort
 Children at home
 Transport difficulties
 Lack of money
 Don’t want surgery
 Poor knowledge about service
 Clinic failures (patient attended)
Bowman et al, 200024 Design: Paired cluster randomized trial of
(A) Health centre based surgery
(B) Village based surgery
Location: Gambia
Number of participants: 158
Follow up period: one year
(A) 44%
(B) 66%
(RR, 1.49; 95% CI,
1.11--2.01; p5 0.009)
 Cost
 Distance
Rabiu and Abiose, 2001102 Design: Cross-sectional
Location: Nigeria
Number of participants: 101
Follow up period: cross-sectional study
90% (of people with TT
had not sought treatment)
 Cost
 Lack of symptoms
 Distance
 Lack of escort
Bowman et al, 200222 Design: Prospective cohort
Location: Gambia
Number of participants: 148
Follow up period: 12 months
23%  Mild symptoms
 Previous bad surgical experience
 Fear
 Happy to epilate
 Using traditional eye medicines
 Family opposition
 Too expensive
 Lack of time
 Lack of escort
 Do not know how to access surgery
 Seasonal income
 Geographic
(continued on next page)
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130 Surv Ophthalmol 57 (2) March--April 2012 RAJAK ET ALsurgical uptake is usually higher in village surgical
campaigns than in health-center-based surgery
(66% vs. 44%; rate ratio, 1.49; 95% CI, 1.11--2.01;
p 5 0.009), with no significant difference in
outcomes.24 In high-prevalence TT settings, both
approaches are likely to be required.
3. Barriers to Surgery
Studies examining barriers to surgery are pre-
sented in Table 4. The acceptance of surgery is
repeatedly shown to be poor, with 18% and 66% of
patients having surgery, even when free transport
and surgery are provided.22,24,40,87,98,102,136 Despite
the different settings of these studies, common
reasons emerge for failure: Logistical barriers in-
clude distance to surgery, lack of transport, lack of
escorts (the majority of TT patients have bilateral
disease and bilateral surgery, making an escort
essential), indirect costs (food, accommodation,
transport, and paying someone to cover work and/
or home duties), and lack of time. Additionally,
when the symptoms are not severe, self-
administered epilation seems a more desirable
treatment, particularly in the context of the poor
outcomes reported from many field trials. There
may be health-system problems, including failure to
inform patients about existing TT surgical services
and equipment/personnel failures that prevent
surgery on eligible patients attending clinic.61 Many
of these barriers can be overcome by moving the
surgery closer to the patient, but this may be
expensive and require complicated planning. The
highest uptake rate (66%) is achieved by providing
surgery at a village level.24
4. The Cost of Treatment
During a 30-year program of surgical treatment in
Burma, the average cost per case of visual impair-
ment prevented by surgical treatment has been
calculated as US$ 193, although this has become
much cheaper in the last ten years (US$ 41),
presumably because of increased efficiency and
decreased capital costs.52 The cost effectiveness of
trachoma surgery in seven regions of the world was
calculated as between US$ 13 and US$ 78 per
disability-adjusted life year (DALY) averted and was
cheapest (US$ 13--17) in Africa, where the greatest
burden lies.9 In Gambia, each operation costs US
$6.13, whereas the estimated life-time loss of pro-
ductivity is estimated to be US$ 89.57 These figures
compare favorably to other ophthalmic operations.
For example the cost effectiveness of cataract
surgery in resource poor settings has been estimated
to range great from US$ 9/quality-adjusted life year
(QALY) to US$ 1,600/QALY.85
TRACHOMATOUS TRICHIASIS IN ENDEMIC COUNTRIES 131X. Conclusion
Trachomatous trichiasis causes visual loss and
blindness and remains a major public health
problem in many low-income countries. Surgery is
the mainstay of treatment and is often effective.
Recurrence rates can be high and uptake low, and
there remains uncertainty about whether all patients
with minor TT require surgical treatment. A
multitude of surgical procedures has been devised
and tried. Bilamellar tarsal rotation and posterior
lamellar tarsal rotation are currently the procedures
of choice, as they are relatively quick and easy to
teach and perform and have lower recurrence rates.
Further research needs to be conducted into
optimal surgical techniques and training and
alternatives for treating minor trichiasis.XI. Method of Literature Search
Articles pertaining to trachomatous trichiasis and
trichiasis surgery were sought using Medline (all
years). The following search terms were used:
trachomatous trichiasis, trachoma and trichiasis, tra-
choma and surgery and barriers, trachoma and opacity,
trichiasis and history, trachoma and history. Non-English
literature was translated into English.Disclosure
The salaries of two of the authors of this paper
(S.R. and M.B.) were funded by grants from the
Band Aid Foundation with Fight For Sight and The
Wellcome Trust (080741/Z/06/Z). The funding
organizations had no role in the design or writing
of this article. The authors reported no proprietary
or commercial interest in any product mentioned or
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